Skip to main content
Therma Bright Inc. logo

Therma Bright Inc. — Investor Relations & Filings

Ticker · THRM ISIN · CA8834262070 LEI · 529900PN7P0GSORO2174 TSXV Manufacturing
Open in API
Filings indexed 525 across all filing types
Latest filing 2020-12-24 Regulatory Filings
Country CA Canada
Listing TSXV THRM

About Therma Bright Inc.

https://www.thermabright.com/

Therma Bright Inc. is a medical technology company that develops, acquires, and markets proprietary diagnostic and medical device technologies for the consumer and institutional healthcare sectors. The company's portfolio addresses key areas including pain management, circulation, diagnostics, and critical care. Core products and development projects include Venowave, a medical device designed to boost circulation and prevent blood clots; the Digital Cough Test (DCT), an AI-powered application developed with AI4LYF for rapid, non-invasive detection of respiratory diseases; and the PREVA™ clot retriever, developed with Inretio for enhanced thrombectomy procedures in ischemic stroke treatment. Furthermore, Therma Bright is advancing inhaled statin therapy in partnership with InVixa for the treatment of COVID-19 pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2020-12-24 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Therma Bright Inc. It announces a material change related to the company's COVID-19 rapid saliva test feasibility study results. The document includes detailed information about the material change, the date of the change, and contact information for the executive officer. It is a regulatory filing specifically reporting a material change event, not a financial report, earnings release, or other types of filings. The presence of the form number 51-102F3 and the nature of the content align with a Regulatory Filing (RNS) category, which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories. The document length is 8481 characters, which is substantive and contains detailed information, confirming it is not a brief announcement or a report publication notice.
2020-12-09 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing preliminary results from feasibility studies for a COVID-19 rapid saliva test by Therma Bright Inc. It discusses development progress, testing plans, regulatory submission intentions, and stock option grants. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The content focuses on product development updates and company announcements rather than financial results or governance changes. This type of document fits best under a general regulatory announcement or company news update category rather than a formal financial or governance report. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other specific categories.
2020-12-09 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled "THERMA BRIGHT INC. MANAGEMENT'S DISCUSSION AND ANALYSIS FOR THE YEAR ENDED JULY 31, 2020" and contains detailed management commentary on the company's financial condition, operating performance, forward-looking statements, business description, product descriptions, and sales strategy. It explicitly states it is a Management's Discussion and Analysis (MD&A) document, which is a detailed explanation of financial results, business trends, and outlook. The document is about the year ended July 31, 2020, indicating it is an annual period report. It is not a full annual report (10-K) but specifically the MD&A section. Therefore, the appropriate classification is Management Reports (MDA). The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification.
2020-12-01 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the annual filings for the financial year ended July 31, 2020. The content is primarily an officer certification regarding the annual filings, without containing actual financial statements or substantive financial data. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than the actual annual report (10-K) or other financial reports. The document length is short (3078 characters) and it is a certification letter, not the report itself.
2020-12-01 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of the annual filings for the financial year ended July 31, 2020. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It explicitly states it is a certification and does not include representations related to internal controls. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or other financial reports.
2020-12-01 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.